Eagle Pharmaceuticals, Inc. Accounts Payable
Eagle Pharmaceuticals, Inc. had Accounts Payable of $15.84 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-08-09
- 2023-06-30: Accounts Payable, Current $15.84M.
- 2023-03-31: Accounts Payable, Current $17.11M.
- 2022-12-31: Accounts Payable, Current $18.99M.
- 2022-09-30: Accounts Payable, Current $13.21M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2023-06-30 | $15.84M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $17.11M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $18.99M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $13.21M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $19.97M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $14.51M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $16.43M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $12.72M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $11.14M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $12.56M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $6.27M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $13.07M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $13.71M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $9.76M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.46M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $11.23M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $17.30M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $16.79M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $9.92M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $7.54M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $18.27M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $9.35M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $11.98M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $8.90M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $12.15M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $19.03M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $14.72M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $13.10M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $11.43M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $10.29M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.86M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $14.15M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $4.78M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $5.43M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $3.50M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $4.06M 10-K · filed 2016-02-29 | |
| 2014-06-30 | $2.52M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $2.46M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | $1.19M 10-K · filed 2014-12-22 | $1.19M 10-Q · filed 2014-05-15 |